V-Notes Hysterectomy in Patients With Endometrial cáncer Compared With Laparoscopic Surgery (Robotically Assisted or Not): ENOLA TRIAL
ENOLA
1 other identifier
interventional
84
1 country
1
Brief Summary
The v-NOTES surgical approach may provide important advantages over the already established effective technique (laparoscopy) for safely and successfully removing the uterus and adnexa in patients with low-grade endometrioid adenocarcinoma FIGO IA and atypical endometrial hyperplasia, such as a better aesthetic outcome, a shorter hospital stays, and a decrease in pain and postoperative complications. without increasing surgical time and with equal safety for the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 27, 2025
CompletedFirst Submitted
Initial submission to the registry
June 27, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedJuly 20, 2025
July 1, 2025
2.9 years
June 27, 2025
July 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Time taken to perform surgery
Surgical time will be defined, in the case of the laparoscopic/robotic route, as the time elapsed from the insertion of the first trocar to the removal of the last one, and in the case of the v-NOTES route, as the time elapsed from the beginning of the vaginal surgery to the end of the surgery. The previous time of positioning of the patient, anesthesia, asepsis and sizing of the surgical field will not be taken into account
Perioperative
Secondary Outcomes (6)
AGE
Day 1
Body Mass Index
Day 1
times spent in surgical techniques
1 day post surgery
Measurement of post-surgical pain
6 and 24 hours after the intervention
Study of overall patient satisfaction upon hospital discharge
Trough study completion, an average of a1 year
- +1 more secondary outcomes
Study Arms (2)
Laparoscopic surgery
ACTIVE COMPARATORwithin the laparoscopic (LPC) arm, 21 patients will be assigned to conventional LPC and another 21 to robotic surgery, consecutively.
surgery via v-NOTES
EXPERIMENTALsurgery via v-NOTES
Interventions
the laparoscopic (LPC) arm, 21 patients will be assigned to conventional LPC and another 21 to robotic surgery, consecutively.
Eligibility Criteria
You may qualify if:
- Age of majority (\> 18 years)
- Willingness to participate in the study and signing of informed consent
- Histological diagnosis, by endometrial biopsy (either using a Cornier cannula or directed by diagnostic hysteroscopy) of atypical endometrial hyperplasia or low-grade endometrioid adenocarcinoma (G1-G2), with an initial stage (IA) at preoperative evaluation
You may not qualify if:
- Pregnant Women
- Nullicottitis
- Severe uterine prolapse (grade IV)
- Large myomatous uterus (greater than 18 weeks of gestation)
- Severe comorbidities that contraindicate surgery, such as sepsis, severe renal failure, severe cardiopulmonary disease, or severe coagulopathies 33
- Presence of previous illnesses or treatments that may have caused severe pelvic adhesions that obliterate the Douglas pouch and prevent vaginal entry, such as deep pelvic endometriosis, severe pelvic inflammatory disease, inflammatory bowel disease (ulcerative colitis, diverticulitis, Crohn's disease), or a history of pelvic radiotherapy, among others
- Concomitant presence of adnexal masses or formations of considerable size that are expected to substantially lengthen the uterus Surgical time due to the difficulty of extraction
- Contraindication to general anesthesia
- Active pelvic or lower urinary tract infection
- Clinical suspicion of advanced stage of the neoplasia
- Any histological type of endometrial cancer other than those described previously.
- High histological grade (G3)
- Current abnormality in cervical cytology (CVC) requiring more aggressive surgical intervention
- Revocation of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HCUVA
Murcia, Murcia, 30120, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rafael Guijarro Campillo, MD
HCUVA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2025
First Posted
July 20, 2025
Study Start
July 11, 2022
Primary Completion
May 27, 2025
Study Completion
May 27, 2025
Last Updated
July 20, 2025
Record last verified: 2025-07